Charles Martin Strom

University Of California Los Angeles

$377,424

Attributed

$2,188,884

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $932.1K · FY2019–24

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$2,188,884 · 2

By mechanism

U01$1,810,584 · 1

UH3$378,300 · 1

Top collaborators

Fang Wei3 shared
David T Wong3 shared
Denise R Aberle2 shared
William Hsu2 shared
Kostyantyn Krysan2 shared
David S Chia1 shared
Guy Soo Hoo1 shared

Most similar at University Of California Los Angeles

Same institution · by research overlap

Denise R Aberle$7,414,266
David T Wong$54,826,713
William Hsu$2,700,990
Fang Wei$3,486,544
David Elashoff$4,613,039

Others in their field

Other Emerging Leaders on “Technology”

Sonia M Thomas · Research Triangle Institute$700,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
Leonard Freedman · Leidos Biomedical Research, Inc.$436,612,396
Valerie Koch · University Corporation For Atmospheric Res$252,793,840
Joel A Lipkin · Four Points Technology, Llc$178,737,225
Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128

Research focus

TechnologyLiquid SubstanceMalignant Neoplasm Of LungPerformanceCancer PatientMeasurementLaboratoriesMalignant - DescriptorMolecularNon-Small-Cell Lung CarcinomaTumor DnaDetectionMortalityCancer DetectionDiagnosisElectric FieldLiquid BiopsyBlood SpecimenBloodDeep LearningComputed Tomography ScreeningCandidate MarkerCollaborationsCurative Treatments

Grant awards (3)

EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment$878,436

U01 · FY2024 · CA

EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment$932,148

U01 · FY2023 · CA

Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients$378,300

UH3 · FY2019 · CA